Campbell & CO Investment Adviser LLC Axogen, Inc. Transaction History

Campbell & CO Investment Adviser LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$8.5 - $10.38 $121,762 - $148,693	14,325 New	14,325 $130,000
Q1 2022 May 09, 2022	SELL	$7.26 - $10.7 $236,676 - $348,820	-32,600 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$8.8 - $16.0 $286,880 - $521,600	32,600 New	32,600 $305,000
Q3 2018 Nov 08, 2018	SELL	$34.05 - $55.9 $150,977 - $247,860	-4,434 Closed	0 $0
Q2 2018 Jul 13, 2018	BUY	$36.15 - $52.5 $160,289 - $232,785	4,434 New	4,434 $223,000
Q1 2018 May 04, 2018	SELL	$24.4 - $40.25 $331,474 - $546,796	-13,585 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$18.5 - $28.6 $450,956 - $697,153	-24,376 Reduced 64.21%	13,585 $384,000
Q3 2017 Nov 13, 2017	BUY	$14.65 - $19.35 $556,128 - $734,545	37,961	37,961 $735,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $763M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.